Paper41735693
Quantitative Analysis of the Effect of Gastrointestinal Water Dynamics on Oral Drug Absorption using a Physiologically Based Integrated Liquid and Intestinal Absorption Drug (ILIAD) Pharmacokinetic Model.
Suzuki S and 2 others. Pharm Res, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Quantitative Analysis of the Effect of Gastrointestinal Water Dynamics on Oral Drug Absorption using a Physiologically Based Integrated Liquid and Intestinal Absorption Drug (ILIAD) Pharmacokinetic Model. Papers, record 41735693. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41735693
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Quantitative Analysis of the Effect of Gastrointestinal Water Dynamics on Oral Drug Absorption using a Physiologically Based Integrated Liquid and Intestinal Absorption Drug (ILIAD) Pharmacokinetic Model.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Intestinal Absorption | Major topic |
| Models, Biological | Major topic |
| Gastrointestinal Tract | Major topic |
| Water | Major topic |
| Humans | |
| Administration, Oral | |
| Midazolam | |
| Cytochrome P-450 CYP3A | |
| Biological Availability | |
| Atenolol | |
| ATP Binding Cassette Transporter, Subfamily B, Member 1 | |
| Permeability | |
| Pharmaceutical Preparations | |
| Computer Simulation | |
| Propanolamines |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 21J12535 | Japan Society for the Promotion of Science | PubMed | ||
| 24K02191 | Japan Society for the Promotion of Science | PubMed |
Source PubMed
References80
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7333059 | Pharmacokinetics of metoprolol in patients with hepatic cirrhosis. | Clin Pharmacokinet | 1981 | https://conductscience.org/library/papers/7333059 | PubMed |
| 2 | 520399 | Food-induced reduction in bioavailability of atenolol. | Eur J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/520399 | PubMed |
| 3 | 20814158 | Prediction of interindividual variability in pharmacokinetics for CYP3A4 substrates in humans. | Drug Metab Pharmacokinet | 2010 | https://conductscience.org/library/papers/20814158 | PubMed |
| 4 | 25616403 | A new physiologically based pharmacokinetic model for the prediction of gastrointestinal drug absorption: translocation model. | Drug Metab Dispos | 2015 | https://conductscience.org/library/papers/25616403 | PubMed |
| 5 | 19418207 | Prediction of human bioavailability from human oral administration data and animal pharmacokinetic data without data from intravenous administration of drugs in humans. | Pharm Res | 2009 | https://conductscience.org/library/papers/19418207 | PubMed |
| 6 | 16639716 | Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions. | J Pharm Sci | 2006 | https://conductscience.org/library/papers/16639716 | PubMed |
| 7 | 9572916 | What surface of the intestinal epithelium is effectively available to permeating drugs? | J Pharm Sci | 1998 | https://conductscience.org/library/papers/9572916 | PubMed |
| 8 | 30776469 | The nested enzyme-within-enterocyte (NEWE) turnover model for predicting dynamic drug and disease effects on the gut wall. | Eur J Pharm Sci | 2019 | https://conductscience.org/library/papers/30776469 | PubMed |
| 9 | 11823753 | Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. | Clin Pharmacol Ther | 2002 | https://conductscience.org/library/papers/11823753 | PubMed |
| 10 | 12724351 | Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane. | J Pharmacol Exp Ther | 2003 | https://conductscience.org/library/papers/12724351 | PubMed |
| 11 | 24751672 | Viscosity-mediated negative food effect on oral absorption of poorly-permeable drugs with an absorption window in the proximal intestine: In vitro experimental simulation and computational verification. | Eur J Pharm Sci | 2014 | https://conductscience.org/library/papers/24751672 | PubMed |
| 12 | 25770030 | Quantitative targeted absolute proteomics for 28 human transporters in plasma membrane of Caco-2 cell monolayer cultured for 2, 3, and 4 weeks. | Drug Metab Pharmacokinet | 2015 | https://conductscience.org/library/papers/25770030 | PubMed |
| 13 | 20368326 | Prediction of human intestinal first-pass metabolism of 25 CYP3A substrates from in vitro clearance and permeability data. | Drug Metab Dispos | 2010 | https://conductscience.org/library/papers/20368326 | PubMed |
| 14 | 15858854 | Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases. | J Pharm Sci | 2005 | https://conductscience.org/library/papers/15858854 | PubMed |
| 15 | 19480549 | Method for predicting the risk of drug-drug interactions involving inhibition of intestinal CYP3A4 and P-glycoprotein. | Xenobiotica | 2009 | https://conductscience.org/library/papers/19480549 | PubMed |
| 16 | 28817288 | In Silico Modeling Approach for the Evaluation of Gastrointestinal Dissolution, Supersaturation, and Precipitation of Posaconazole. | Mol Pharm | 2017 | https://conductscience.org/library/papers/28817288 | PubMed |
| 17 | 17542022 | Variability in Caco-2 and MDCK cell-based intestinal permeability assays. | J Pharm Sci | 2008 | https://conductscience.org/library/papers/17542022 | PubMed |
| 18 | 29720472 | Predicting Human Clearance of Organic Anion Transporting Polypeptide Substrates Using Cynomolgus Monkey: In Vitro-In Vivo Scaling of Hepatic Uptake Clearance. | Drug Metab Dispos | 2018 | https://conductscience.org/library/papers/29720472 | PubMed |
| 19 | 15734296 | Effect of liquid volume and food intake on the absolute bioavailability of danazol, a poorly soluble drug. | Eur J Pharm Sci | 2005 | https://conductscience.org/library/papers/15734296 | PubMed |
| 20 | 7886130 | [The protein binding of talinolol]. | Pharmazie | 1995 | https://conductscience.org/library/papers/7886130 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CYP3A4 | 1576 | PubTator's text mining | https://conductscience.org/library/genes/1576 | NCBI Gene |
| PGP | 283871 | PubTator's text mining | https://conductscience.org/library/genes/283871 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41735693
GET https://conductscience.org/api/papers/v1/41735693/references?page=2